Table 1 |.
Affected genes | FAD mutations | Number of patients with seizures (study population percentage) | Age at onset of cognitive deficits, years (mean) | Refs |
---|---|---|---|---|
APP | KM670/671NL | 10 (50%) | 44–61 (53) | 244 |
APP | V717L, V717G or V717I | 11 (40%) | 40–67 (51) | 245–248 |
APP | T714I or 714A | 6 (85%) | 33–55 (NA) | 249,250 |
APP | Duplication | 27 (45%) | 39–62 (NA) | 144,145,251–253 |
APP; PSEN1 | KM670/671NL (APP); H163Y (PSEN1) | 8 (89%) | 44–65 (54) | 254 |
PSEN1 | M146L | 7 (70%) | 33–46 (39) | 255 |
PSEN1 | M146V | 1 (100%) | 39 (NA) | 256 |
PSEN1 | L286V | 7 (64%) | 39–56 (48) |
257
|
APP, amyloid precursor protein; FAD, familial Alzheimer’s disease; NA, not available; PSEN1, presenilin-1.